Tim Funnell
Partner • Monograph Capital
Tim trained as a Pharmacologist with Undergraduate degree from University of Cambridge and DPhil from the University of Oxford before joining the Boston Consulting Group’s London office. Since then Tim has been a biotech investor and company-builder at Syncona, Third Rock Ventures, and Oxford Sciences, gaining experience across therapeutic modalities and geographies. Tim leads Monograph’s investments in Aviado and Ascend.
Also speaking
Elsa Abranches
Senior Director – Head of Cell Therapy Bioprocess Development and Manufacturing • AstraZeneca
20 May 2022
Event Info
2022 Spotlight Roundtables
Take a look at the 2022 sample attendee list for Advanced Therapies Europe here.
8 August 2022
